Rui Daniel Prediger
Overview
Explore the profile of Rui Daniel Prediger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
686
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pereira A, Poli A, Matheus F, da Silva L, Fadanni G, Izidio G, et al.
Behav Brain Res
. 2020 Feb;
383:112517.
PMID: 32006562
The systemic administration of low reserpine (RES) doses (0.1-1.0 mg/kg) has been proposed as a valuable rat model for the study of non-motor symptoms of Parkinson's disease (PD). Here, we...
22.
de Paula G, de Oliveira J, Engel D, Cristiane Lopes S, Moreira E, Figueiredo C, et al.
Nutr Neurosci
. 2020 Jan;
24(12):978-988.
PMID: 31910791
Although the benefits of moderate intake of red wine in decreasing incidence of cardiovascular diseases associated to hypercholesterolemia are well recognized, there are still widespread misconceptions about its effects on...
23.
Marques N, Binder L, Roversi K, Sampaio T, Constantino L, Prediger R, et al.
Behav Brain Res
. 2019 Jun;
372:112014.
PMID: 31212060
The dorsolateral striatum (DLS) processes motor and non-motor functions and undergoes extensive dopaminergic degeneration in Parkinson's disease (PD). Beyond the nigrostriatal pathway, dopaminergic degeneration also affects other brain areas including...
24.
de Carvalho Cartagenes S, Fernandes L, Carvalheiro T, de Sousa T, Gomes A, Monteiro M, et al.
Oxid Med Cell Longev
. 2019 Apr;
2019:5452727.
PMID: 31001375
Ketamine is used in clinical practice as an anesthetic that pharmacologically modulates neurotransmission in postsynaptic receptors, such as NMDA receptors. However, widespread recreational use of ketamine in "party drug" worldwide...
25.
Sampaio T, de Souza B, Roversi K, Schuh T, Poli A, Takahashi R, et al.
Neuropharmacology
. 2019 Apr;
151:98-111.
PMID: 30959019
Noradrenergic degeneration in the locus coeruleus (LC) seems a convergent neuropathological marker of different neurodegenerative diseases. Herein, we investigated the temporal development of apoptotic signaling activation in the LC, noradrenergic...
26.
Gomes F, Flores R, Bruxel M, da Silva F, Moreira E, Zoccal D, et al.
Front Neurosci
. 2019 Jan;
12:1020.
PMID: 30686986
There is a mutual relationship between metabolic and neurodegenerative diseases. However, the causal relationship in this crosstalk is unclear and whether Parkinson's disease (PD) causes a posterior impact on metabolism...
27.
Ferre S, Diaz-Rios M, Salamone J, Prediger R
J Caffeine Adenosine Res
. 2019 Jan;
8(4):121-131.
PMID: 30596206
Recent studies on interactions between striatal adenosine and dopamine and one of its main targets, the adenosine A receptor-dopamine D receptor (A2AR-D2R) heteromer, have provided a better understanding of the...
28.
Sampaio T, de Oliveira L, Constantino L, Costa A, Poluceno G, Martins W, et al.
Neurotox Res
. 2018 Jul;
34(3):649-659.
PMID: 29968149
The neonatal exposure to general anesthetics has been associated with neuronal apoptosis and dendritic spines morphologic changes in the developing brain. Ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, is widely...
29.
Remor A, da Silva R, de Matos F, Glaser V, de Paula Martins R, Ghisoni K, et al.
Mol Neurobiol
. 2018 Jun;
56(3):1539-1557.
PMID: 29948953
Chronic metabolic alterations may represent a risk factor for the development of cognitive impairment, dementia, or neurodegenerative diseases. Hyperglycemia and obesity are known to imprint epigenetic markers that compromise the...
30.
Leal R, Lopes M, Formolo D, de Carvalho C, Hoeller A, Latini A, et al.
Mol Psychiatry
. 2018 Jun;
25(3):655-665.
PMID: 29880883
Fear is a conscious state caused by exposure to real or imagined threats that trigger stress responses that affect the body and brain, particularly limbic structures. A sub-group of patients...